Treating wounds with an extract taken from wild blueberries may improve healing, according to a new study. The research will be presented this week in Philadelphia at the American Physiological Society's (APS) annual meeting ...
Apr 3, 2022
0
7
In a new study from Vanderbilt University Medical Center, 10-second videos of white blood cell motion in the skin's microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would ...
Mar 29, 2022
0
106
Most of us know someone affected by hearing loss, but we may not fully appreciate the hardships that lack of hearing can bring. Hearing loss can lead to isolation, frustration, and a debilitating ringing in the ears known ...
Mar 29, 2022
2
422
Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.
Mar 28, 2022
0
13
Columbia Engineering researchers report that they have developed a "cloaking" system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer ...
Mar 17, 2022
0
77
(HealthDay)—A new lung cancer drug that has only been tested in China was soundly rejected by an advisory panel to the U.S. Food and Drug Administration on Thursday.
Feb 11, 2022
0
4
Many types of cancer exhibit changes in their cellular metabolism. These contribute to the development and progression of cancer. Metabolic reprogramming has thus been recognized as a hallmark of cancer and may represent ...
Dec 14, 2021
0
3
Mortality rates for corona patients requiring mechanical ventilation is around 50%, and there are only a few effective treatment options. However, new research results indicate that a well-known drug, already being used at ...
Nov 29, 2021
0
52
When the pro-inflammatory pair, a receptor called CCR2 and its ligand CCL-2, get together, it increases the risk of developing type 1 diabetes, scientists report.
Nov 16, 2021
0
110
A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic COVID by more than 80 percent up to eight months after receiving the treatment, the US biotech firm said Monday.
Nov 8, 2021
0
9
